BIO names John Crowley as new CEO
The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the …
The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the …
Image: U.S. National Archives and Records Administration/Creative Commons Throughout her life, Rosalynn Carter was a true champion of public health. During her time as …
Clinical trial diversity has been one of the most pressing needs in the healthcare industry for decades. For this and many other reasons, the …
BIO unveils updated resources to improve clinical trial diversity Read More »
Pharmacy benefit managers, or PBMs, have been in the political hot seat for a couple of years now—and for good reason. “Every day PBMs …
As PBM reform maintains steam, biotech companies and patients are urged to take action Read More »
“We have 87 million patients in America who rely on Medicaid for either supplemental or primary coverage,” began Virginia McMillin of Jazz Pharmaceuticals during …
“The Inflation Reduction Act (IRA) was one of President Biden’s signature achievements and will help many Americans,” began Christina Hochul of Alexion Pharmaceuticals, Inc., …
Inflation Reduction Act: Unintended consequences for rare disease, orphan drugs Read More »
The 2023 Biotechnology Innovation Organization (BIO) Investor Forum ended the way it began: with caution about the months ahead and hope companies will continue …
The market outlook for life science – and how biotechs can weather the storm Read More »
Artificial Intelligence (AI) is saturating every aspect of human life—including life sciences. While the potential of AI and computational biology are vast, one of …
How AI and computational biology can help us reach ‘undruggable’ targets Read More »
The wonder of RNA-based technology was long in its coming. But it has paid off throughout the COVID and post-COVID years. Plus, the breadth …
RNA presents challenges, enormous opportunities, say biotech leaders Read More »
The only constant is change. The trick for entrepreneurs and investors, it would seem, is to map and anticipate that change and operate with …
What investors look for in early-stage companies Read More »